We provide biotech and pharma regulatory consulting services to support global clinical trials and marketing applications. Innovative Regulatory Inc. offers in depth regulatory strategy and scientific expertise across various therapeutic modalities and jurisdictions, including vaccines, anti-toxins, small molecules, therapeutics, monoclonal/bi-specific antibodies, plasma derived products, synthetic protein therapies, devices, and combination products, covering Canada, US, EU and other global markets. We have a proven track record in all special and expedited regulatory pathways. Our services are flexible and tailored to meet client needs from a technical, strategic and leadership perspective. Innovative Regulatory Inc can prepare and review submission packages and health authority meeting briefing documents, review R&D project plans, and can also provide interim Regulatory leadership solutions as required.